Background: Artesunate (AS) is an artemisinin antimalarial drug used as a single drug or in combination with other antimalarials. Objective: This study was to find its effect on some brain biomolecules and behavioural activities in Wistar rats. Methods:Forty adult male Wistar rats weighing between 150-180g were divided into four groups of A, B, C and D with 10 animals each. Group A served as the control that received tap water, while groups B, C and D served as the experimental groups that received 2.85mg/kg (therapeutic dose-TD) and 5.71mg/kg (high pharmacologic dose-HPD) of AS per day for 3 days, and 2.85mg/kg (long duration therapeutic dose -LDTD) of AS per day for six days respectively. Half of the dose was administered twelve hourly (twice a day), and twelve hours after the last treatments, behaviour test using the 'open field maze' was carried out. Immediately after, the animals were sacrificed with chloroform anaesthesia and the whole brain removed and weighed. Whole brain homogenates were used to determine brain total protein (TP), triacylglycerol (TAG) and cholesterol (CH).Data were analyzed statistically by ANOVA and Tukey-Kramer Multiple Comparative Test as applicable. Results: There were no difference (p<0.05) between the experimental groups and the control group in the anthropometric parameters and behavioural activities. In the brain biomolecules concentration, TP was lower in concentration in the HPD group, TAG was lower in concentration in the LDTD group, while the HPD and LDTD groups had lower CH concentration compared to the control. In all the parameters studied no difference was found between the TD group and the control. Conclusion: AS at recommended dose may not affect some behaviour and brain biomolecule concentration, unlike when taken in excess of dose and or time. Even at these doses/time there may have been no behavioural manifestation.
combating malaria in the world [5] [6] [7] . They act rapidly on the parasites and do not remain in the blood stream for long 8 , therefore most of the parasites are destroyed before the drug concentrations drop to sub-therapeutic levels, reducing the chances that the parasites will form resistance 9 . In clinical trials, artesunate (AS), a derivative of artemisinin, has been reported to destroy cancer cells 10 , and also reduces proliferation, interferes in DNA replication and cell cycle and, enhances apoptosis 11 .
activities against various strains of Plasmodia and preferential activities on one or more stages of the parasite's development 1 . Even at this, the parasites have evolved a way of getting round the potency of most of these drugs [2] [3] [4] .
The potency of the artemisinins and its derivatives makes them highly effective in
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Effect of Artesunate on Brain Biomolecules
It is documented that AS and other derivatives of artemisinin cause significant toxic effects. In the nervous system, they cause damage to the brain stem and other centers involved predominantly in auditory processing and vestibular reflexes [12] [13] [14] [15] [16] . Sedative effects, lowered movement of synchronism, analgesia, muscle relaxation, tremor and convulsion have been reported 17 . These effects are usually due to the release of free radicals from its endoperoxide bond 18 , and free radicals have been implicated in a lot of adverse effects in different parts of the body [18] [19] [20] .
The effects of this drug as it affects the different parts of the brain usually range from the alteration in the biochemical activities to cellular damage and behavioural manifestation [13] [14] [15] [16] [17] . The biochemical activities involve the alteration in the biomolecules concentration and activities within the tissues, while the behavior of animals as affected by endogenous and exogenous agents like drugs may only be appreciated using specialized apparatus such as the open field, Morris water and elevated plus mazes. When studying locomotion, exploratory and anxiety as combined parameters, the open field maze is usually employed 21, 22 . Hence, this study aimed to check the effect of AS on some behavioral activities and some biomolecules in the brain of Wistar rats.
Methods
Forty adult male Wistar rats weighing between 150-180g procured from the animal house of the Department of Anatomy were handled in accordance with the International regulation governing the use of laboratory animals. The animals were randomly assigned into four groups (A, B, C, and D) of ten animals each. Group A served as the control, while groups B, C and D were the experimental. Two packets of standard AS drug were procured from a reputable pharmacy in Calabar. Each packet contained twelve 50mg blistered tablets of AS. Clean tap water was used as vehicle to dissolve the drug and the mg/kg body weights equivalent to a physiologic man was calculated as the therapeutic dose. The control group received a placebo of tap water, while the experimental groups received different doses of AS, all by oro-gastric tubes. The animals were treated twelve hourly (twice daily). The treatment is as seen in Table - 21, 22 .
Rats were carried to the test room in home cages and were handled by the base of their tails at all times. Each rat was placed in the proximal righthand corner of the maze and allowed to explore the apparatus for five minutes. After the five minute test, the rat was returned in its home cage and the open field was cleaned with 70% ethyl alcohol and permitted to dry before introduction of the next rat. Behavior was scored manually, and each trial was recorded for latter analysis using a video camera positioned above the apparatus. The counting was done manually.
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The following activities were carried out: frequency of line crossing; frequency of central square entry (CSF), central square duration (CSD); frequency of rearing; frequencies of stretch-attend (SA); urination and defecation 21, 22 .
Immediately after the behaviour test, the animals were sacrificed using chloroform anaesthesia. Their brains were immediately removed, blotted dry on filter paper and weighed using a Mettler p163 balance. They were homogenized in cold 0.25m STKM (sucrose tris-KCl-MgCl) buffer. The homogenates were then used to estimate total protein (TP), triacylglycerol (TAG) and cholesterol (CH). The homogenization procedure involved rinsing the brain in cold 0.25m STKM buffer, crushing in mortar and homogenization in cold 0.25m STKM buffer. The homogenates were washed into a volumetric flask and made up to 15ml using STKM buffer. Aliquots of the homogenates were spurned using a centrifuge. The supernatant of the aliquots were then used for TP estimation using Biuret kit, TAG estimation using GPO-PAP kit and CH estimation using CHOP-PAP kit methods.
Statistical analysis using a one-way analysis of variance (ANOVA) was used to compare the group's mean for the body and brain weights, open field parameters and brain biomolecules, for treatment and their interactions. Thereafter post-hoc test using Tukey-Kramer Multiple Comparative Test was carried out to find the level of significance at p<0.05. All the results were expressed as mean ± standard error of mean.
Results
There was no significant (p = 0.0857) difference in the body weights of the animals in the experimental groups compared to the control, as well as no difference among the experimental groups. There was no significant (p = 0.4942) difference in the body weights of the animals in the experimental groups compared to the control, as well as no difference among the experimental groups. This is as seen in Table - II. Result are presented as mean ± standard error of mean, n = 10, NS = Not significantly different from the group A at p < 0.05, TD = Therapeutic dose, HPD = High pharmacologic dose, LDTD = Long duration therapeutic dose
There was no urination in all the groups, hence the reason it was not represented on Table -III. There was no significant difference (p = 0128) between the experimental groups and the control, but the LDTD group was significantly (p < 0.01) lower than the TD group. This is as seen in Table - III. The HPD group had a significantly lower (p = 0.0046) TP concentration compared to the control and the TD groups. There were no significant difference between the TD, and LDTD groups and the control group. The LDTD group was significantly lower (p < 0.05) than the TD, HPD and the control groups, while there was no difference between the other experimental groups and the control. The HPD and LDTD groups were significantly lower (p < 0.05) than the control group, though there was no difference between these groups and the TD group. There was however no difference between the TD group and the control. This is as seen in Table - IV. 
Discussion
AS is a water-soluble form of artemisinin, and is effective as an antimalarial agent. In this study, AS effects on some brain biomolecules and behavior were investigated. The anthropometric parameters revealed insignificant (p=0.0857, 0.4942) difference between the treatment groups and the control in the body and brain weights respectively. This implies that the AS treatment at these doses and time did not affect the body and brain weights of the animals. This is consistent with a previous report 23 .
The behavior of animals requires special attention and specialized study, because we may not appreciate most of these different behaviours exhibited ordinarily. Hence, the use of the open field maze for locomotion, exploratory and anxiety related behaviours. TLA measures locomotor activity, exploration and anxiety, CSF and CSD measure exploration and anxiety, while SA, urination, and defecation, measure anxiety [21] [22] [23] [24] [25] . High frequencies of TLA, CSF and CSD, indicate increased locomotion, exploration and decreased anxiety, whereas the high frequencies of SA, urination, and defecation, indicate increased anxiety.
In this study, there was no difference between the experimental groups and the control group in TLA, CSF, CSD and SA, while there was no urination in all the groups. This indicates that the behaviours of the animals were not altered after treatment with AS. The LDTD group had a significant reduced defecation than the HPD group. Hall et al 24 33 . Thus, the depletion of the store of CH may limit the activities of the brain since lipids play a significant role in myelination, signal transmission, membrane formation, and determine the entry and exist of signaling molecules and ions 34 . Depletion of these lipids might result in alteration of these functions that may result in catastrophic implications.
In both brain biomolecule concentration and behavioural activities, the TD group was not different from the control group. This may be that the drug treatment may not have adverse effects at recommended dose. Behavioural activities are usually the manifestation of biochemical and cellular processes, which if drastic predisposes one to elevated or depressed behaviour. Increased behavioural activities are mostly due to activation of the brain which later manifests as excitation of the central neurons and an increased in cerebral metabolism. This was not the case in this study and may imply that the biomolecule changes may have been transient. Genovese et al 35 reported neurotoxicity in the absence of deficits in behavioural performance in rats using arteether, another derivative of artemisinin.Our study revealed that changes were only observed in the biomolecule
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Effect of Artesunate on Brain Biomolecules concentration of the HPD and LDTD groups treated with 5.71mg/kg and 2.86mg/kg of AS per day for 3 and 6 days respectively. These doses were more than the recommended doses and time of the drug.
Conclusion
We then conclude that AS may not be harmful at its recommended dose, since its effect was not different from the control in the anthropometric parameters, behavioural activities and biomolecule concentration studies. Thus, AS at recommended dose may not affect some behaviour and brain biomolecule concentration, unlike when taken in excess of dose and or time.
Even at these doses/time there may have been no behavioural manifestation. 
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